ProMIS Neurosciences Inc. (PMN)
$10.89
$0.04
(0.37%)
As on 22-May-2026 11:26EDT
Market cap
$94 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
1.6
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1.2 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
1.4
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-22.4
-
Face value
--
-
Shares outstanding
8,967,693
9 Years Aggregate
CFO
$-10,891.98 Mln
EBITDA
$-72.03 Mln
Net Profit
$-62.07 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
ProMIS Neurosciences Inc (PMN)
| 59.6 | 1.5 | -32.3 | -12.2 | -57.3 | 23.9 | 25.9 |
|
BSE Sensex
| -10.9 | -4.9 | -8.9 | -7.6 | 6.9 | 8.3 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
ProMIS Neurosciences Inc (PMN)
| -71.2 | -17.5 | -73.5 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
ProMIS Neurosciences Inc (PMN)
|
10.9 | 93.6 | 0.0 | -40.6 | -- | -116.2 | -- | 1.6 |
| 3.5 | 363.2 | 68.1 | -67.3 | -104.0 | -83.9 | -- | 6.1 | |
| 18.3 | 1,095.5 | 0.0 | -167.9 | -- | -128.7 | -- | 5.3 | |
| 27.8 | 1,862.3 | 1,043.8 | 488.8 | -19.0 | 16 | 3.2 | 0.5 | |
| 26.8 | 15,765.8 | 8,837.9 | 2,614.3 | 36.5 | 45.7 | 19.5 | 2.9 | |
| 13.1 | 906.1 | 106,763.2 | 5,307.0 | 5.8 | 2147 | 67.5 | 3.3 | |
| 3.0 | 507.5 | 4.0 | -198.4 | -5,037.7 | -166.3 | -- | 7.6 | |
| 6.5 | 294.3 | 0.8 | -75.0 | -8,478.9 | -121.5 | -- | 5.5 | |
| 5.9 | 546.2 | 156.8 | -138.6 | -16.6 | -121.9 | -- | 6.1 | |
| 18.5 | 2,090.4 | 453.3 | -178.1 | -38.4 | -25.1 | -- | 3.1 |
Shareholding Pattern
View DetailsAbout ProMIS Neurosciences Inc (PMN)
ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS, which enables... drug discovery through a combination of protein biology, physics, and supercomputing. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers for treating Alzheimer's disease; PMN267 for the treatment of amyotrophic lateral sclerosis; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils for treating multiple system atrophy. The company also develops PNM440, an alpha-synuclein vaccine for treating multiple synucleinopathies; and PMN311, an amyloid-beta vaccine for the treatment of Alzheimer's. In addition, it is developing therapies for frontotemporal lobar degeneration, Huntington's disease, progressive supranuclear palsy, corticobasal degeneration, and schizophrenia. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. is headquartered in Toronto, Canada. Address: 1920 Yonge Street, Toronto, ON, Canada, M4S 3E2 Read more
-
Co-Founder & Chairman
Mr. Eugene Williams
-
Co-Founder & Chairman
Mr. Eugene W. Williams
-
Headquarters
Toronto, ON
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for ProMIS Neurosciences Inc (PMN)
What is the current share price of ProMIS Neurosciences Inc (PMN) Today?
The share price of ProMIS Neurosciences Inc (PMN) is $10.89 (NASDAQ) as of 22-May-2026 11:26 EDT. ProMIS Neurosciences Inc (PMN) has given a return of -57.31% in the last 3 years.
What is the current PB & PE ratio of ProMIS Neurosciences Inc (PMN)?
Since, TTM earnings of ProMIS Neurosciences Inc (PMN) is negative, P/E ratio is not available.
The P/B ratio of ProMIS Neurosciences Inc (PMN) is 1.55 times as on 20-May-2026, a 71 discount to its peers’ median range of 5.26 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-0.34
|
-10.85
|
|
2024
|
0.34
|
0.06
|
|
2023
|
--
|
--
|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
What is the 52 Week High and Low of ProMIS Neurosciences Inc (PMN)?
The 52-week high and low of ProMIS Neurosciences Inc (PMN) are Rs 39.75 and Rs 6.27 as of 22-May-2026.
What is the market cap of ProMIS Neurosciences Inc (PMN)?
ProMIS Neurosciences Inc (PMN) has a market capitalisation of $ 94 Mln as on 20-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in ProMIS Neurosciences Inc (PMN)?
Before investing in ProMIS Neurosciences Inc (PMN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.